definiens: shall mean, to the extent ( i ) Controlled by [COMPANY] and arising after the Closing Dateduring the License Term and ( ii ) introduced by [COMPANY] for use 15 with a Licensed Product under a Development Plan or generated under such a Development Plan, and in either case used witha Licensed Product, all information, know - how, trade secrets, techniques, methods, processes, assays, inventions ( including, without limitation, all unpatented and unpatentable Inventions owned solely by [COMPANY] or owned jointly by GW Pharma andOtsuka, but not those Inventions as to which patent applications are pending, which Inventions shall be dealt with inaccordance with Sections 1.63 and 7.2 ), developments, materials, or compositions of matter of any type or kind, marketingreports, expertise, formulas, technology, and including, in relation to commercialization of a Licensed Product, confidentialinformation relating to the commercialization of such Licensed Product in the Territory, designs used in the trade dress of aLicensed Product in the Territory and any form of advertisement in whatever media or other marketing or promotionalmaterials which have been generated by or upon behalf of [COMPANY], its Affiliates, or sub - licensees in relation tocommercialization of Licensed Products in the Territory, but in each case excluding the GW Pharma Know - How, the GWPharma Patent Rights, Pre - Clinical Data, [COMPANY] Patent Rights, [COMPANY] Clinical Data, the Joint Patents, and all [COMPANY] businessmethods and systems including, but not limited to, software and procedures using in accounting, finance, sales, and thecollection of safety data